Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic Raises $10M

NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.

The Boulder, Colo.-based protein biomarker discovery and clinical diagnostics company declined to comment on the financing. In its Form D document, it said that it had one investor in the round but did not identify the investor. SomaLogic did not say how proceeds will be used.

The privately held firm raised $19.5 million in 2003 in a Series C private financing round. In 2009, it received a $15 million investment from Quest Diagnostics as part of a diagnostic development deal, and in late 2003, SomaLogic received two investments totaling $11 million from two Japanese firms.

Last week, the company and Agilent Technologies announced a deal to expand SomaLogic's SOMAscan protein biomarker discovery platform.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.